"Metrolina Internal Medicine is an independently owned and privately operated practice proudly serving Charlotte for over 26 years. We specialize in the prevention, diagnosis and treatment of adult and non-surgical diseases, in addition to providing in-office preventive health screenings. Call us today."

During the past decade, Metrolina Internal Medicine conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 16 clinical trials were completed, i.e. on average, 177.8% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 9 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Metrolina Internal Medicine" #1 sponsor was "AstraZeneca" with 4 trials, followed by "Bristol-Myers Squibb" with 4 trials sponsored, "Eli Lilly and Company" with 4 trials sponsored, "Gilead Sciences" with 2 trials sponsored and "Idorsia Pharmaceuticals Ltd." with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Metrolina Internal Medicine" #1 collaborator was "Astra Zeneca, Bristol-Myers Squibb" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Janssen Biotech, Inc." with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Metrolina Internal Medicine" are "Hypertension" (5 trials), "Type 2 Diabetes" (4 trials), "Diabetes Mellitus, Type 2" (3 trials), "Cardiovascular Disease" (2 trials) and "Obesity" (2 trials). Many other conditions were trialed in "Metrolina Internal Medicine" in a lesser frequency.

Most popular intervention types in "Metrolina Internal Medicine" are "Drug" (22 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Dapagliflozin" (3 trials), "Saxagliptin" (3 trials), "Aprocitentan 25 mg" (2 trials) and "Darusentan" (2 trials). Other intervention names were less common.

The vast majority of trials in "Metrolina Internal Medicine" are 23 trials for "All" genders.

Currently, there are NaN active trials in "Metrolina Internal Medicine". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Metrolina Internal Medicine, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Metrolina Internal Medicine, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".